Results 81 to 90 of about 52,732 (301)
Opioid receptor types and dependence.
The existence of mu, delta and kappa opioid receptors in the central nervous system is well documented. The present review focuses on the relationships between opioid receptor types and physical and psychic dependences. Mu and delta, but not kappa opioid receptor agonists produce physical dependence.
SUZUKI, Tsutomu, MISAWA, Miwa
openaire +3 more sources
Abstract Background Postoperative opioids, intended for short‐term analgesia, contribute to new persistent opioid use in 1%–7% of patients, adversely affecting outcomes. Oxycodone may carry higher risk than morphine, though long‐term data are limited.
Eward J. Melis +5 more
wiley +1 more source
Medication-assisted treatment of opioid dependence information toolkit. [PDF]
This information kit developed by researchers at the National Drug and Alcohol Research Centre at UNSW provides a step by step guide to the evidence for medically assisted treatment for heroin dependence as well as answering commonly asked questions ...
Dolan, Kate, Mehrjerdi, Zahra Alam
core
The Medical Outcome Study Short Form 36 (SF-36) is one of the most commonly used questionnaires for monitoring the Health-Related Quality of Life (HRQOL) of opioid-dependent patients.
Hsiao, Yu-Yu; Shih, Ching-Lin; Yu, Wan-Hui; Hsieh, Cheng-Hsi; Hsieh, Ching-Lin
core +1 more source
Abstract Aims We studied the prevalence of psychotropic use and psychotropic polypharmacy in persons with Parkinson's disease (PD) during a 10‐year follow‐up, because longitudinal studies on this topic are scarce although non‐motor symptoms of PD are often treated with psychotropics.
Noora Nieminen +4 more
wiley +1 more source
Place of buprenorphine in the management of opioid dependence
Buprenorphine is a partial agonist at μ opioid receptors and has been used extensively in pain management. Its use in the management of opioid dependence has occurred in the last decade although its potential has been recognized from the late 1970s ...
Mattick, Richard P. +2 more
core
Aims Paediatric pharmacokinetics differ significantly from adults due to age‐related physiological changes, necessitating precise dose adjustments. However, data on therapeutic drug monitoring (TDM) implementation in paediatric setting remain limited.
Gianluca Gazzaniga +20 more
wiley +1 more source
Single high-dose buprenorphine for opioid craving during withdrawal
Background Opioid use disorder is one of the most prevalent addiction problems worldwide. Buprenorphine is used as a medication to treat this disorder, but in countries where buprenorphine is unavailable in combination with naloxone, diversion can be a ...
Jamshid Ahmadi +3 more
doaj +1 more source
Opioid Dependence in Pregnancy [PDF]
Sunesh, Kumar +5 more
openaire +2 more sources
Background Reporting adverse drug reactions (ADRs) is essential for drug safety. In Switzerland, healthcare professionals are legally required to report serious and unlabelled ADRs, yet under‐reporting remains widespread. We tested a novel method to increase reporting of ADR‐related hospitalizations.
Georgia Anita Weber +7 more
wiley +1 more source

